Identification of PFKFB3 as a key factor in the development of colorectal cancer and immunotherapy resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of PFKFB3 as a key factor in the development of colorectal cancer and immunotherapy resistance

Published:2024-09-12 Issue:1 Volume:24 Page:
ISSN:1591-9528
Container-title:Clinical and Experimental Medicine
language:en
Short-container-title:Clin Exp Med

Author:

Lu Si,Zhao Rongjie,Han Yicheng,Shao Shengpeng,Ji Yaming,Zhang Jinku,Pan Hongming,Sun Jiachun,Feng Yuxiong

Funder

National Natural Science Foundation of China

Baoding Technology Project

Natural Science Foundation of Hebei Province

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10238-024-01479-w.pdf

Reference46 articles.

1. Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

2. Wu Q, et al. Survival outcomes of stage I colorectal cancer: development and validation of the ACEPLY model using two prospective cohorts. BMC Med. 2023. https://doi.org/10.1186/s12916-022-02693-7.

3. Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325(7):669–85.

4. Dekker E, et al. Colorectal cancer. Lancet. 2019;394(10207):1467–80.

5. Le DT, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409–13.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3